Market Place
Sourcing Support
Enzymatica`s New CEO Drives International Expansion Phase
18 Feb 2026 //
PR NEWSWIRE
Enzymatica AB: Reports Strong Q3/2025: Growth In Sweden
30 Oct 2025 //
PR NEWSWIRE
Enzymatica AB Sees Strong Growth in Sweden
17 Jul 2025 //
PR NEWSWIRE
Studies Show ColdZyme Reduces Respiratory Infections & Sick Days
28 Feb 2025 //
PR NEWSWIRE
Enzymatica AB 2024 Year-end Report: Strong Core Market Performance
18 Feb 2025 //
PR NEWSWIRE
Enzymatica AB Reports Q3 2024 Focus on Market Expansion
07 Nov 2024 //
PR NEWSWIRE
Enzymatica`s Board Approves SEK 130 Million Rights Issue
18 Jul 2024 //
PR NEWSWIRE
Notice of Extraordinary General Meeting in Enzymatica AB (publ)
18 Jul 2024 //
PR NEWSWIRE
Interim report Q2/2024: Enzymatica builds momentum for expansion
18 Jul 2024 //
PR NEWSWIRE
Bulletin from annual general meeting of Enzymatica AB (publ) on May 7, 2024
07 May 2024 //
PR NEWSWIRE
Enzymatica: MDR Cert Opens Great Commercial Opportunities in Q1
25 Apr 2024 //
PR NEWSWIRE
Enzymatica publishes information memorandum about rights issue of shares
19 Feb 2024 //
PR NEWSWIRE
Enzymatica`s Board of Directors decides on new rights issue of SEK 27.4 million
16 Feb 2024 //
PR NEWSWIRE
New study: ColdZyme breaks viral infection cycle
22 Aug 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.